Top Markets
Coin of the day
Epigenomics AG Epigenomics AG

Epigenomics AG

ECX
Kedudukan dalam Saham #38936
Founded in 1998 and headquartered in Berlin, Germany, Epigenomics AG is a... Founded in 1998 and headquartered in Berlin, Germany, Epigenomics AG is a molecular diagnostics company dedicated to the early detection of cancer through liquid biopsy methods. Its primary offering, Epi proColon, is a blood-based assay specifically developed for the early identification of colorectal cancer, distributed across the United States, Europe, and China. The company's portfolio further encompasses a blood test for hepatocellular carcinoma and Epi BiSKit, a pre-analytical solution providing reagents essential for preparing bisulfite-converted DNA. Epigenomics' research and development initiatives are focused on pinpointing relevant biomarkers in human tissue and subsequently creating and securing patents for associated in vitro diagnostic blood tests.
Harga Saham
$0.83030862
Disegerakkan terakhir: 2024-06-27
Modal Pasaran
$726.64K
Perubahan (1 hari)
-1.35%
Perubahan (1 tahun)
0.00%
Negara
DE
Perdagangan Epigenomics AG (ECX)

Kategori

Sejarah pecahan saham untuk Epigenomics AG (ECX)
Saham Epigenomics AG (simbol: ECX) telah mengalami sejumlah 0 pecahan saham.
Pecahan saham terkini berlaku pada Aug 14, 2026.
Satu saham ECX yang dibeli sebelum Aug 14, 2026 kini bersamaan dengan 0 saham ECX.
Senarai pecahan saham
Tahun Pecahan Gandaan Gandaan Kumulatif
Tidak cukup data untuk tarikh yang disediakan.
Pecahan saham untuk syarikat pesaing atau serupa
Syarikat Bilangan pecahan saham Gandaan Kumulatif Negara
8 x34
US
7 x47
US
0 -
CN
4 x15
US
0 -
US